DOCSLIB.ORG

Understanding the Endocannabinoid System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Understanding the Endocannabinoid System CBD: MECHANISM OF ACTION 4 KEY CONSIDERATIONS FOR COMPOUND: Cannabidiol (CBD) CBD has multiple molecular targets that extend beyond the classical cannabinoid receptors. CBD is one of approximately 100 phytocannabinoids naturally occurring in hemp plants. Cannabinoids By inhibiting fatty acid amide hydrolase (FAAH), the enzyme that degrades anandamide, CBD SELECTING QUALITY CBD refer to molecules found in the cannabis plant that interact with cannabinoid receptors. Common activates cannabinoid receptors indirectly. cannabinoids include: D9-THC, THCV, CBD, CBDV, CBG and CBC. THC-free — non- Solvent-free, clean detectable and every C02 extraction batch tested Fatty Acid Amide Hydrolase GPR55 KEY FACTS: Understanding the ECS inhibition receptor inhibition 100% US-sourced, IC ~10 –20µM 50 IC <0.5µM UNDERSTANDING • Plays vital neurological and immunomodulatory roles that can affect overall health 50 CBD Colloidal delivery field-grown agricultural FAAH systems for enhanced hemp • Comprised of specialized eicosanoids, known as endocannabinoids, that the body makes from THE ENDOCANNABINOID lipid precursors bioavailability Anandamide PPARγ SYSTEM (ECS) activation EC50 = 5µM 1. 2. 3. Adenosine reuptake inhibition High-quality CBD products provide a high-potency dosage per IC 50 <5µM capsule, broad-spectrum support from phytocannabinoids, CBCB1 CB2 gluten-free CB1, CB 2 beta-caryophyllene and other terpenes, and are Legend receptor Low-affinity interaction supported by and non-GMO. activation limited/inconclusive data Endocannabinoids Cannabinoid Enzymes TRPV1 Low-to moderate-affinity interaction 1. Anandamide Receptors that control Vanilloid receptor supported by satisfactory data 5HT1A endocannabinoid activation/ 2. 2-Arachidonoylglycerol (2-AG) Serotonin receptor Potent interaction supported by levels activation desensitization satisfactory data EC 50 <5µM EC 50 = 0.007µM DOUGLAS L A B O R A T O R I E S ©2019 Douglas Laboratories. DOUGLAS L A B O R A T O R I E S DLQFHM519 All rights reserved. THE ECS IN THE CNS THE ECS IN THE PERIPHERY INFLUENCE ON SEROTONIN IMPORTANCE OF ENHANCED The two major endocannabinoids — anandamide and 2-AG — activate two different cannabinoid The CB receptor is located primarily in the gut, immune system, and periphery, where it modulates the 2 SIGNALING BIOAVAILABILITY receptors: CB1 and CB2. The CB1 receptor is primarily expressed on neurons in the brain and immune response and downregulates the production of cytokines, such as IL-6, IL-1β, TNFα, IFNβ, and IFNγ. nervous systems; a main function is to inhibit excitatory neurotransmission. The levels of anandamide and 2-AG are tightly controlled by the balance of synthesis and degradation. • Colloidal delivery systems: water-soluble Water-soluble colloidal droplets allow even dispersion of CBD and droplets cross the intestinal CBD facilitates neurotransmission water layer for better terpenes in the GI tract absorption. Presynaptic neuron mediated by the serotonin 5HT1A In cells of the immune system, receptor. • Droplets easily cross the water layer at the Once activated, the CB1 receptor Anandamide or 2-AG 1 3 GI tract, and other peripheral tissues, intestinal brush border, a major absorption WATER LAYER inhibits further release of the (endocannabinoids) stimulating neurotransmitter, endocannabinoids (primarily 2-AG) activate obstacle for lipophilic compounds Anandamide or 2-AG eliciting a relaxant effect. CB2 receptors. MUCOSA While cannabidiol (endocannabinoids) Beta-caryophyllene CB supports endocannabinoid signaling indirectly, BLOODSTREAM 1 Excitatory neurotransmitter Inflammatory cytokines beta-caryophyllene (eg. glutamate) (e.g. TNF-α, IL-6, IFNγ) is a direct CB2 agonist, Endocannabinoids potentially sharing similar 2 CB1 activate CB1 receptors, immunomodulating effects CBD has poor bioavailability CB2 which are located on as the endocannabinoids. due to its lipophilic properties. the presynaptic neuron. More research is needed to explore this effect in humans. The intestinal brush border is coated with a Once activated, CB2 water layer, which normally limits the absorption 2 receptors elicit many of fat-soluble compounds. Enclosing CBD and CBD increases levels of the endocannabinoid immunomodulating 1 Excitatory neurotransmitters anandamide by inhibiting its reuptake and activate endocannabinoid effects, which depend terpenes in a water-soluble droplet improves degradation. As a result, more anandamide synthesis and release. on the cell type and is available to activate cannabinoid receptors. Neurotransmitter its environment. the uptake of these bioactives across the water receptor layer, allowing better absorption. The enzyme that CBD modulates is known as FAAH. CB2 activation modifies 3 Endocannabinoid inflammatory cytokine production, which has In the limbic system of the ENZYMES synthesis NERVE STIMULATION broad clinical implications. brain, activation of this receptor contributes to calming effects. Improving water solubility with a colloidal Postsynaptic neuron Degradation technology greatly enhances absorption and To learn more visit increases plasma levels of CBD. douglaslabs.com.
Load more

Recommended publications
  • Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
    International Journal of Molecular Sciences Review Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System Shenglong Zou and Ujendra Kumar * Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-604-827-3660; Fax: +1-604-822-3035 Received: 9 February 2018; Accepted: 11 March 2018; Published: 13 March 2018 Abstract: The biological effects of cannabinoids, the major constituents of the ancient medicinal plant Cannabis sativa (marijuana) are mediated by two members of the G-protein coupled receptor family, cannabinoid receptors 1 (CB1R) and 2. The CB1R is the prominent subtype in the central nervous system (CNS) and has drawn great attention as a potential therapeutic avenue in several pathological conditions, including neuropsychological disorders and neurodegenerative diseases. Furthermore, cannabinoids also modulate signal transduction pathways and exert profound effects at peripheral sites. Although cannabinoids have therapeutic potential, their psychoactive effects have largely limited their use in clinical practice. In this review, we briefly summarized our knowledge of cannabinoids and the endocannabinoid system, focusing on the CB1R and the CNS, with emphasis on recent breakthroughs in the field. We aim to define several potential roles of cannabinoid receptors in the modulation of signaling pathways and in association with several pathophysiological conditions. We believe that the therapeutic significance of cannabinoids is masked by the adverse effects and here alternative strategies are discussed to take therapeutic advantage of cannabinoids. Keywords: cannabinoid; endocannabinoid; receptor; signaling; central nervous system 1. Introduction The plant Cannabis sativa, better known as marijuana, has long been used for medical purpose throughout human history.
    [Show full text]
  • N-Acyl-Dopamines: Novel Synthetic CB1 Cannabinoid-Receptor Ligands
    Biochem. J. (2000) 351, 817–824 (Printed in Great Britain) 817 N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Tiziana BISOGNO*, Dominique MELCK*, Mikhail Yu. BOBROV†, Natalia M. GRETSKAYA†, Vladimir V. BEZUGLOV†, Luciano DE PETROCELLIS‡ and Vincenzo DI MARZO*1 *Istituto per la Chimica di Molecole di Interesse Biologico, C.N.R., Via Toiano 6, 80072 Arco Felice, Napoli, Italy, †Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, R. A. S., 16/10 Miklukho-Maklaya Str., 117871 Moscow GSP7, Russia, and ‡Istituto di Cibernetica, C.N.R., Via Toiano 6, 80072 Arco Felice, Napoli, Italy We reported previously that synthetic amides of polyunsaturated selectivity for the anandamide transporter over FAAH. AA-DA fatty acids with bioactive amines can result in substances that (0.1–10 µM) did not displace D1 and D2 dopamine-receptor interact with proteins of the endogenous cannabinoid system high-affinity ligands from rat brain membranes, thus suggesting (ECS). Here we synthesized a series of N-acyl-dopamines that this compound has little affinity for these receptors. AA-DA (NADAs) and studied their effects on the anandamide membrane was more potent and efficacious than anandamide as a CB" transporter, the anandamide amidohydrolase (fatty acid amide agonist, as assessed by measuring the stimulatory effect on intra- hydrolase, FAAH) and the two cannabinoid receptor subtypes, cellular Ca#+ mobilization in undifferentiated N18TG2 neuro- CB" and CB#. NADAs competitively inhibited FAAH from blastoma cells. This effect of AA-DA was counteracted by the l µ N18TG2 cells (IC&! 19–100 M), as well as the binding of the CB" antagonist SR141716A.
    [Show full text]
  • N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation Via Nonhematopoietic TRPV1
    N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1 This information is current as Samira K. Lawton, Fengyun Xu, Alphonso Tran, Erika of October 1, 2021. Wong, Arun Prakash, Mark Schumacher, Judith Hellman and Kevin Wilhelmsen J Immunol 2017; 199:1465-1475; Prepublished online 12 July 2017; doi: 10.4049/jimmunol.1602151 http://www.jimmunol.org/content/199/4/1465 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/07/12/jimmunol.160215 Material 1.DCSupplemental http://www.jimmunol.org/ References This article cites 69 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/199/4/1465.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on October 1, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice Freely available online through The Journal of Immunology Author Choice option Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1 Samira K.
    [Show full text]
  • Role of the Endocannabinoid System and Medical Cannabis
    Brigham Young University BYU ScholarsArchive Student Works 2016-12-19 Role of the Endocannabinoid System and Medical Cannabis Sabrina Jarvis Brigham Young University, [email protected] Sean Rasmussen Brigham Young University, [email protected] Blaine Winters Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/studentpub Part of the Nursing Commons The College of Nursing showcases some of our best evidence based scholarly papers from graduate students in the Family Nurse Practitioner Program. The papers address relevant clinical problems for advance practice nurses and are based on the best evidence available. Using a systematic approach students critically analyze and synthesize the research studies to determine the strength of the evidence regarding the clinical problem. Based on the findings, recommendations are made for clinical practice. The papers are published in professional journals and presented at professional meetings. BYU ScholarsArchive Citation Jarvis, Sabrina; Rasmussen, Sean; and Winters, Blaine, "Role of the Endocannabinoid System and Medical Cannabis" (2016). Student Works. 192. https://scholarsarchive.byu.edu/studentpub/192 This Master's Project is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Student Works by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Role of the Endocannabinoid System and Medical Cannabis Sean I. Rasmussen An evidence based scholarly paper submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Masters of Science Sabrina Jarvis, Chair Blaine Winters College of Nursing Brigham Young University Copyright © 2016 Sean I.
    [Show full text]
  • Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back
    International Journal of Molecular Sciences Review Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back Osnat Almogi-Hazan * and Reuven Or Laboratory of Immunotherapy and Bone Marrow Transplantation, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; [email protected] * Correspondence: [email protected] Received: 21 May 2020; Accepted: 19 June 2020; Published: 23 June 2020 Abstract: The Cannabis plant contains numerous components, including cannabinoids and other active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid system. Cannabinoids affect the nervous system and play significant roles in the regulation of the immune system. While Cannabis is not yet registered as a drug, the potential of cannabinoid-based medicines for the treatment of various conditions has led many countries to authorize their clinical use. However, the data from basic and medical research dedicated to medical Cannabis is currently limited. A variety of pathological conditions involve dysregulation of the immune system. For example, in cancer, immune surveillance and cancer immuno-editing result in immune tolerance. On the other hand, in autoimmune diseases increased immune activity causes tissue damage. Immuno-modulating therapies can regulate the immune system and therefore the immune-regulatory properties of cannabinoids, suggest their use in the therapy of immune related disorders. In this contemporary review, we discuss the roles of the endocannabinoid system in immunity and explore the emerging data about the effects of cannabinoids on the immune response in different pathologies. In addition, we discuss the complexities of using cannabinoid-based treatments in each of these conditions.
    [Show full text]
  • Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
    molecules Review Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious? Stephen Schultz 1, Georgianna G. Gould 1, Nicola Antonucci 2, Anna Lisa Brigida 3 and Dario Siniscalco 4,* 1 Department of Cellular and Integrative Physiology, Center for Biomedical Neuroscience, University of Texas (UT) Health Science Center San Antonio, San Antonio, TX 78229, USA; [email protected] (S.S.); [email protected] (G.G.G.) 2 Biomedical Centre for Autism Research and Therapy, 70126 Bari, Italy; [email protected] 3 Department of Precision Medicine, University of Campania, 80138 Naples, Italy; [email protected] 4 Department of Experimental Medicine, University of Campania, 80138 Naples, Italy * Correspondence: [email protected] Abstract: Persistent deficits in social communication and interaction, and restricted, repetitive pat- terns of behavior, interests or activities, are the core items characterizing autism spectrum disorder (ASD). Strong inflammation states have been reported to be associated with ASD. The endocannabi- noid system (ECS) may be involved in ASD pathophysiology. This complex network of lipid signal- ing pathways comprises arachidonic acid and 2-arachidonoyl glycerol-derived compounds, their G-protein-coupled receptors (cannabinoid receptors CB1 and CB2) and the associated enzymes. Alter- Citation: Schultz, S.; Gould, G.G.; ations of the ECS have been reported in both the brain and the immune system of ASD subjects. ASD Antonucci, N.; Brigida, A.L.; Siniscalco, D. Endocannabinoid children show low EC tone as indicated by low blood levels of endocannabinoids. Acetaminophen System Dysregulation from use has been reported to be associated with an increased risk of ASD.
    [Show full text]
  • The Cannabinoid WIN 55,212-2 Prevents Neuroendocrine Differentiation of Lncap Prostate Cancer Cells
    OPEN Prostate Cancer and Prostatic Diseases (2016) 19, 248–257 www.nature.com/pcan ORIGINAL ARTICLE The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells C Morell1, A Bort1, D Vara2, A Ramos-Torres1, N Rodríguez-Henche1 and I Díaz-Laviada1 BACKGROUND: Neuroendocrine (NE) differentiation represents a common feature of prostate cancer and is associated with accelerated disease progression and poor clinical outcome. Nowadays, there is no treatment for this aggressive form of prostate cancer. The aim of this study was to determine the influence of the cannabinoid WIN 55,212-2 (WIN, a non-selective cannabinoid CB1 and CB2 receptor agonist) on the NE differentiation of prostate cancer cells. METHODS: NE differentiation of prostate cancer LNCaP cells was induced by serum deprivation or by incubation with interleukin-6, for 6 days. Levels of NE markers and signaling proteins were determined by western blotting. Levels of cannabinoid receptors were determined by quantitative PCR. The involvement of signaling cascades was investigated by pharmacological inhibition and small interfering RNA. RESULTS: The differentiated LNCaP cells exhibited neurite outgrowth, and increased the expression of the typical NE markers neuron-specific enolase and βIII tubulin (βIII Tub). Treatment with 3 μM WIN inhibited NK differentiation of LNCaP cells. The cannabinoid WIN downregulated the PI3K/Akt/mTOR signaling pathway, resulting in NE differentiation inhibition. In addition, an activation of AMP-activated protein kinase (AMPK) was observed in WIN-treated cells, which correlated with a decrease in the NE markers expression. Our results also show that during NE differentiation the expression of cannabinoid receptors CB1 and CB2 dramatically decreases.
    [Show full text]
  • Cannabinoids: Novel Molecules with Significant Clinical Utility
    CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY NOEL ROBERT WILLIAMS MD FACOG DIRECTOR OPTIMAL HEALTH ASSOCIATES OKLAHOMA CITY, OKLAHOMA How Did We Get Here? • In November 2012 Tikun Olam, an Israeli medical cannabis facility, announced a new strain of the plant which has only CBD as an active ingredient, and virtually no THC, providing some of the medicinal benefits of cannabis without euphoria. The Researchers said the cannabis plant, enriched with CBD, “can be used for treating diseases like rheumatoid arthritis, colitis, liver inflammation, heart disease and diabetes.” Cannabis CBD like in this article is legally derived from the hemp plant. • CBD is the major non-psychoactive component of Cannabis Sativa (Hemp). Hemp plants are selectively developed and grown to contain high amounts of CBD and very low amounts of the psychoactive component THC found in marijuana. A few CBD oil manufacturers further purify their products to contain high amounts of CBD and no THC. 2014 Farm Bill Terminology • Active Ingredient • Zero THC • Cannabidiol • Isolate • PCR – Phytocannabinoid-Rich • Hemp Oil Extract • “Recommendation” vs. “Prescribed” • Full Spectrum Endocannabinoids (AEA) Phytocannabinoids Full Spectrum & Active Ingredient • CBD – Cannabidiol • A major phytocannabinoid, accounting for as much as 85% of the plant’s extract • CBC – Cannabichromene • Anti-inflammatory & anti-fungal effects have been seen • CBG – Cannabigerol • The parent molecule from which many other cannabinoids are made • CBDV – Cannabidivarin • A homolog of CBD that has been reported to have powerful anti-convulsive effects • CBN – Cannabinol • Sleep & Appetite regulation • Terpenes • Wide spectrum of non-psychoactive molecules that are know to act on neural receptors and neurotransmitters, enhance norepinephrine activity, and potentially increases dopamine activity.
    [Show full text]
  • Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-Eicosa-5,8,11,14-Tetraenamide]
    0022-3565/06/3173-1365–1371$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 317, No. 3 Copyright © 2006 by The American Society for Pharmacology and Experimental Therapeutics 100792/3113920 JPET 317:1365–1371, 2006 Printed in U.S.A. Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide] G. La Rana,1 R. Russo,1 P. Campolongo, M. Bortolato, R. A. Mangieri, V. Cuomo, A. Iacono, G. Mattace Raso, R. Meli, D. Piomelli, and A. Calignano Department of Experimental Pharmacology, University of Naples, Naples, Italy (G.L.R., R.R., A.I., G.M.R., R.M., A.C.); Department of Human Physiology and Pharmacology, University of Rome “La Sapienza,” Rome, Italy (P.C., V.C.); and Department of Pharmacology and Center for Drug Discovery, University of California, Irvine, California (M.B., R.A.M., D.P.) Received December 29, 2005; accepted February 28, 2006 ABSTRACT The endocannabinoid system may serve important functions in (30 mg/kg i.p.). Comparable effects were observed with the central and peripheral regulation of pain. In the present UCM707 [N-(3-furylmethyl)-eicosa-5,8,11,14-tetraenamide], study, we investigated the effects of the endocannabinoid another anandamide transport inhibitor. In both the chronic transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa- constriction injury and complete Freund’s adjuvant model, daily 5,8,11,14-tetraenamide] on rodent models of acute and persis- treatment with AM404 (1–10 mg/kg s.c.) for 14 days produced tent nociception (intraplantar formalin injection in the mouse), a dose-dependent reduction in nocifensive responses to ther- neuropathic pain (sciatic nerve ligation in the rat), and inflam- mal and mechanical stimuli, which was prevented by a single matory pain (complete Freund’s adjuvant injection in the rat).
    [Show full text]
  • The Role of the Endocannabinoid System
    International Journal of Molecular Sciences Review The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System Annia A. Martínez-Peña 1,2,†, Genevieve A. Perono 1,2,† , Sarah Alexis Gritis 2, Reeti Sharma 3, Shamini Selvakumar 3, O’Llenecia S. Walker 2,3, Harmeet Gurm 2,3, Alison C. Holloway 1,2 and Sandeep Raha 2,3,* 1 Graduate Program in Medical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada; [email protected] (A.A.M.-P.); [email protected] (G.A.P.); [email protected] (A.C.H.) 2 Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON L8S 4K1, Canada; [email protected] (S.A.G.); [email protected] (O.S.W.); [email protected] (H.G.) 3 Department of Pediatrics, McMaster University, Hamilton, ON L8S 4K1, Canada; [email protected] (R.S.); [email protected] (S.S.) * Correspondence: [email protected]; Tel.: +1-905-521-2100 (ext. 76213) † These authors contributed equally to the preparation of this manuscript. Abstract: Cannabis use during pregnancy has continued to rise, particularly in developed countries, as a result of the trend towards legalization and lack of consistent, evidence-based knowledge on the matter. While there is conflicting data regarding whether cannabis use during pregnancy leads to adverse outcomes such as stillbirth, preterm birth, low birthweight, or increased admission to neonatal intensive care units, investigations into long-term effects on the offspring’s health are limited. Historically, studies have focused on the neurobehavioral effects of prenatal cannabis exposure on Citation: Martínez-Peña, A.A.; the offspring.
    [Show full text]
  • N-Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic Potential
    Molecular Pharmacology Fast Forward. Published on November 14, 2017 as DOI: 10.1124/mol.117.110841 This article has not been copyedited and formatted. The final version may differ from this version. MOL #110841 1 MINIREVIEW N-Acyl amino acids (Elmiric Acids): endogenous signaling molecules with therapeutic potential Sumner H. Burstein Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605 Downloaded from molpharm.aspetjournals.org at ASPET Journals on September 30, 2021 Molecular Pharmacology Fast Forward. Published on November 14, 2017 as DOI: 10.1124/mol.117.110841 This article has not been copyedited and formatted. The final version may differ from this version. MOL #110841 2 Running title. N-Acyl amino acids; endogenous signaling molecules Corresponding author: Sumner H. Burstein, Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605 [email protected] Phone: 508-856-2850 FAX: 508-856-2251 Number of of text pages, 26 Number of tables, 3 Downloaded from Number of figures, 4 Number of references, 60 Number of words in the: molpharm.aspetjournals.org Abstract, 220 Introduction, 742 Discussion, 6338 Abbreviations: COX, cyclooxygenase; FAAH, fatty acid amide hydrolase; GABA, γ- at ASPET Journals on September 30, 2021 aminobutyric acid; GPCR, G-protein coupled receptor; LXA4, lipoxin A4 ; LOX, 12,14 lipoxygenases; PGJ,15-deoxy-Δ -prostaglandin-J2 Molecular Pharmacology Fast Forward. Published on November 14, 2017 as DOI: 10.1124/mol.117.110841 This article has not been copyedited and formatted. The final version may differ from this version. MOL #110841 3 Abstract The subject of N-acyl amino acid conjugates has been rapidly growing in recent years, especially with regard to their analgesic and anti-inflammatory actions.
    [Show full text]
  • Noladin Ether, a Putative Novel Endocannabinoid
    FEBS Letters 513 (2002) 294^298 FEBS 25828 View metadata, citation and similar papers at core.ac.uk brought to you by CORE Noladin ether, a putative novel endocannabinoid: inactivationprovided by Elsevier - Publisher Connector mechanisms and a sensitive method for its quanti¢cation in rat tissues Filomena Fezzaa, Tiziana Bisognoa, Alberto Minassib, Giovanni Appendinob, Raphael Mechoulamc, Vincenzo Di Marzoa;Ã aEndocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Comprensorio Olivetti, Fabbricato 70, 80078 Pozzuoli (Naples), Italy bDiSCAFF, Universita© del Piemonte Orientale, Viale Ferrucci 33, 28100 Novara, Italy cDepartment of Medicinal Chemistry and Natural Products, Faculty of Medicine, Hebrew University, Jerusalem 91120, Israel Received 16 November 2001; revised 22 January 2002; accepted 23 January 2002 First published online 31 January 2002 Edited by Judit Ova¨di The 2-AGE binds selectively to CB vs. CB cannabinoid Abstract The occurrence of the novel proposed endocannabi- 1 2 noid, noladin ether (2-arachidonyl glyceryl ether, 2-AGE) in receptors, functionally activates CB1 receptors, and induces various rat organs and brain regions, and its inactivation by responses typical of cannabimimetic compounds in the mouse intact C6 glioma cells, were studied. 2-AGE was measured by `tetrad' of behavioral tests in vivo [6,7]. Evidence of de novo isotope dilution liquid chromatography-atmospheric pressure biosynthesis and inactivation in brain cells is, however, neces- chemical ionization-mass spectrometry, with a detection limit sary before 2-AGE can reach the status of an endogenous of 100 fmol. A compound with the same mass and chromato- neuronal mediator. Both these criteria are ful¢lled by AEA graphic/chemical properties as 2-AGE was found in whole brain, and 2-AG, which are produced from arachidonic acid (AA)- with the highest amounts in the thalamus and hippocampus.
    [Show full text]